Results 291 to 300 of about 71,732 (355)
We developed and internally validated a machine learning–based survival model for predicting long‐term progression of dPD. Supported by SHAP analysis, the model identified that depressive symptom severity, cognitive impairment, and autonomic dysfunction were the main key clinical predictors for dPD progression.
Defu Liu +14 more
wiley +1 more source
GTP release-selective agonists prolong opioid analgesic efficacy. [PDF]
Stahl EL +6 more
europepmc +1 more source
This registry‐based analysis of 1183 MS clinical trials (2004–2024) shows sustained global activity and a marked increase in mainland China after 2018, predominantly driven by late‐phase and bioequivalence studies. Trial density varied across regions, and IFNAR, CD20, and S1PR1 were the most frequently investigated targets. ABSTRACT Background Multiple
Chaoyang Chen +7 more
wiley +1 more source
Evaluating the association between migraine treatments and tinnitus: Insights from the US Food and Drug Administration adverse event reporting system. [PDF]
Kim Y, Yook Y, Rhee SJ.
europepmc +1 more source
Vitamin D as a Regulator of the Biological Clock-Implications for Circadian-Metabolic Dysregulation. [PDF]
Vesković M +6 more
europepmc +1 more source
Structural Pharmacology of Bufotenine Derivatives in Activating the 5-HT<sub>1A</sub> Receptor for Therapeutic Potential in Depression and Anxiety. [PDF]
Li SJ +16 more
europepmc +1 more source
Weight Regain After GLP-1-Based Therapy Discontinuation: Failure, Physiology, or Follow-Up Gap. [PDF]
Quimbayo-Cifuentes AF.
europepmc +1 more source
Adrenergic signaling during parasitic infections. [PDF]
Gardias P, Bąska P.
europepmc +1 more source

